Sabra director granted 781 dividend-equivalent units

Sabra Health Care REIT director Michael J. Foster reported an acquisition of stock units tied to common stock.

Rhea-AI Filing Summary

Sabra Health Care REIT director Michael J. Foster reported an acquisition of stock units tied to common stock. On February 27, 2026, he was credited with 781 stock units as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan, at a stated price of $0.00 per unit.

These new units will vest and become payable on the same schedule as the original stock units they track. After this credit, Foster directly holds 74,719 shares of common stock, which include 2,854 unvested stock units and 51,345 vested stock units with deferred payment, each representing the right to receive one share. He also indirectly holds 42,411.745 shares through a 401(k) plan.

Insider Trade Summary

Grant/Award: 781 shares

Grant/Award 2 txns

Insider FOSTER MICHAEL J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	781	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 74,719 shares (Direct); Common Stock — 42,411.745 shares (Indirect, 401(k) Plan)

Footnotes (2)

1. F1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
2. F2. Includes 2,854 unvested stock units and 51,345 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Michael J. Foster report for Sabra Health Care REIT (SBRA)?

Michael J. Foster reported an acquisition of 781 stock units tied to Sabra Health Care REIT common stock. These units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and follow the same vesting terms.

Was cash paid for the 781 stock units acquired by Sabra Health Care REIT director Michael J. Foster?

No cash changed hands for this transaction; the 781 stock units were credited at a price of $0.00 per unit. They represent dividend equivalents on already outstanding stock units, calculated using the market value of the common stock on the dividend payment date.

How many Sabra Health Care REIT shares does Michael J. Foster hold after this Form 4 filing?

After this filing, Michael J. Foster directly holds 74,719 shares of Sabra Health Care REIT common stock. This direct position includes 2,854 unvested stock units and 51,345 vested but deferred stock units, each representing the right to receive one share of common stock.

What additional indirect holdings does Michael J. Foster report in Sabra Health Care REIT (SBRA)?

In addition to his direct position, Michael J. Foster reports 42,411.745 shares of Sabra Health Care REIT common stock held indirectly through a 401(k) Plan. This reflects retirement-plan ownership separate from his directly held and deferred stock unit positions reported in the filing.

How do the newly credited stock units for Michael J. Foster at Sabra Health Care REIT vest?

The 781 newly credited stock units will vest and become payable on the same terms as the original stock units they track. They are dividend equivalent units tied to earlier grants, mirroring those awards’ vesting schedule under the 2009 Performance Incentive Plan.

What are the vested and deferred stock units reported by Michael J. Foster at Sabra Health Care REIT?

Michael J. Foster’s holdings include 51,345 stock units that have already vested, but payment has been deferred. Each stock unit represents the right to receive one share of Sabra Health Care REIT common stock at a future settlement date chosen under the plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 02:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FOSTER MICHAEL J

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CA 92782

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		781(1)	A	$0	74,719(2)	D
Common Stock								42,411.745	I	401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

2. Includes 2,854 unvested stock units and 51,345 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.